PDS Biotechnology Corp (PDSB)
3.37
-0.16
(-4.53%)
USD |
NASDAQ |
May 20, 16:00
3.37
0.00 (0.00%)
After-Hours: 16:16
PDS Biotechnology Cash from Financing (Quarterly): 20.01M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 20.01M |
| December 31, 2023 | 10.77M |
| September 30, 2023 | 0.8023M |
| June 30, 2023 | 0.24M |
| March 31, 2023 | 4.568M |
| December 31, 2022 | 9.707M |
| September 30, 2022 | 24.55M |
| June 30, 2022 | 0.0224M |
| March 31, 2022 | 0.0075M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.1235M |
| June 30, 2021 | 48.77M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 17.79M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 12.04M |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.75M |
| December 31, 2018 | -21.49M |
| September 30, 2018 | 0.1698M |
| June 30, 2018 | -0.0035M |
| March 31, 2018 | 1.052M |
| December 31, 2017 | 0.0284M |
| September 30, 2017 | 0.0472M |
| June 30, 2017 | 22.42M |
| March 31, 2017 | 0.0547M |
| December 31, 2016 | 0.0079M |
| September 30, 2016 | 10.70M |
| June 30, 2016 | -0.5271M |
| March 31, 2016 | -1.096M |
| December 31, 2015 | 84.60M |
| September 30, 2015 | -0.234M |
| June 30, 2015 | 52.24M |
| March 31, 2015 | 2.918M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2019
48.77M
Maximum
Jun 2021
7.470M
Average
0.1818M
Median
Cash from Financing (Quarterly) Benchmarks
| Syros Pharmaceuticals Inc | -0.265M |
| PAVmed Inc | 19.05M |
| Palatin Technologies Inc | 9.136M |
| iBio Inc | 4.005M |
| Chromocell Therapeutics Corp | 0.1981M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -9.938M |
| Free Cash Flow | -30.39M |
| Free Cash Flow Per Share (Quarterly) | -0.2855 |
| Free Cash Flow Yield | -28.13% |